Zhi Xiong Chen — investor profile photo

Zhi Xiong Chen

Senior Lecturer and Chair of Inquiry & Thinking Pathway

📍 Singapore, Singapore🔄 Updated November 2026💼 3 investments📅 13 years investing🗓 Last invested Feb 2020
Angel investor🌍 Singapore
3
Total investments
1
Early stage
0
Mid stage
0
Late stage
13y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Principal Investigator
Dec 2013
The Vision of N2CR is simple – To develop innovative new ways to detect, cure or prevent cancer. The NUS Centre for Cancer Research (N2CR), hopes to develop new ways to detect, cure and prevent cancer through internationally leading fundamental research. The programme aims to advance our understanding of cancer and translate research discoveries into clinical practice that benefits patients. The programme’s emphasis on interdisciplinary collaboration will bring fundamental researchers in biomedical sciences together with scientists and engineers to develop enabling technology to address major scientific or clinical challenges.
early stage
Experience · 3 entries
All (3)
Investments (3)
Board (1)
2020
Board Member
Feb 2020
IAMSE is a nonprofit professional development society organized and directed by health professions educators whose goals include promoting excellence and innovation in teaching, student assessment, program evaluation, instructional technology, human simulation, and learner-centered education.
2013
Yong Loo Lin School of Medicine, National University of Singapore
Principal Investigator
Dec 2013
Principal Investigator
Dec 2013
The Vision of N2CR is simple – To develop innovative new ways to detect, cure or prevent cancer. The NUS Centre for Cancer Research (N2CR), hopes to develop new ways to detect, cure and prevent cancer through internationally leading fundamental research. The programme aims to advance our understanding of cancer and translate research discoveries into clinical practice that benefits patients. The programme’s emphasis on interdisciplinary collaboration will bring fundamental researchers in biomedical sciences together with scientists and engineers to develop enabling technology to address major scientific or clinical challenges.
early stage
Investment activity
2013–2020 · 3 investments
2013220201
Recent (last 2 years)Earlier